Trial Profile
A Non Interventional Trial of Tarceva Metastatic Non Small Lung Cancer.
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 28 Jan 2016
Price :
$35
*
At a glance
- Drugs Erlotinib (Primary)
- Indications Non-small cell lung cancer
- Focus Therapeutic Use
- Sponsors Roche
- 06 Nov 2015 New trial record